Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors.

By M. Studeny, F. Marini, R. Champlin, C. Zompetta, I. J. Fidler, Michael Andreeff. Cancer Research, 2002

988 citations recorded by the source corpus.

View Paper: https://www.semanticscholar.org/paper/b30b5d9c62cabe81233b7a24d11403aef9f55ac2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Erika L Spaeth
2. J. Dembinski
3. A. Nakamizo
4. F. Marini
5. A. Sasser
6. A. Klopp
7. Keri Watson
8. T. Amano

Citations in the corpus

• Mesenchymal Stem Cell Transition to Tumor-Associated Fibroblasts Contributes to Fibrovascular Network Expansion and Tumor Progression (2009, background): “In those and subsequent studies, we demonstrated that MSC, administered intravenously, were able to integrate and persist within tumor stroma of pre-established human melanoma, breast cancer and glioma xenografts [11,12,16].”
• Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. (2005, methodology): “(Qbiogene, Irvine, CA) as described previously (27).”